Gingival hypertrophy in a kidney transplant recipient

Abderrahmane Mabrouk; Yanis Tamzali; Benoit Barrou; Jérôme Tourret

doi:10.1111/ajt.17110

Gingival hypertrophy in a kidney transplant recipient

Am J Transplant. 2022 Sep;22(9):2273-2275. doi: 10.1111/ajt.17110.

Authors

Abderrahmane Mabrouk¹, Yanis Tamzali^{1

2}, Benoit Barrou^{1

3}, Jérôme Tourret^{1

2}

Affiliations

¹ Assistance Publique-Hôpitaux de Paris AP-HP, Pitié-Salpêtrière Hospital, Medical and Surgical Department of Kidney Transplantation, Paris, France.
² Sorbonne Université, INSERM UMR 1138, Paris, France.
³ Sorbonne Université, INSERM U 1082, Paris, France.

PMID: 36039542
DOI: 10.1111/ajt.17110

No abstract available

Keywords: clinical research/practice; immunosuppressant - calcineurin inhibitor: Tacrolimus; immunosuppression/immune modulation; kidney transplantation/nephrology; nutrition; physician education; solid organ transplantation.

MeSH terms

Calcineurin Inhibitors
Gingival Hypertrophy*
Graft Rejection
Graft Survival
Humans
Immunosuppressive Agents
Kidney Transplantation* / adverse effects
Tacrolimus
Transplant Recipients

Substances

Calcineurin Inhibitors
Immunosuppressive Agents
Tacrolimus